Loading clinical trials...
Loading clinical trials...
An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Prospective, Multicenter, Open Label, Single Arm, Intervention Study to Assess Efficacy and Safety of an At-home, Game-based Digital Therapy for Treating Clinical Symptoms of Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)
Conditions
Interventions
ADHD Therapy
Locations
5
United States
CNS Healthcare of Jacksonville
Jacksonville, Florida, United States
Accel Clinical Research Sites
Lakeland, Florida, United States
Rochester Center for Behavioral Medicine (RCBM)
Rochester Hills, Michigan, United States
Midwest Research Group
Brentwood, Missouri, United States
Hassman Research Institute
Berlin, New Jersey, United States
Start Date
April 15, 2023
Primary Completion Date
March 1, 2025
Completion Date
June 1, 2025
Last Updated
December 31, 2024
NCT07478458
NCT07465081
NCT06655610
NCT07314333
NCT06906328
NCT04526600
Lead Sponsor
Lumos Labs, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions